AH

Adam D. Hughes

TI Theravance Biopharma R&D Ip: 5 patents #2 of 51Top 4%
TC Theravance Respiratory Company: 1 patents #1 of 8Top 15%
📍 Rue de l'Église, CA: #5 of 84 inventorsTop 6%
🗺 California: #3,228 of 67,890 inventorsTop 5%
Overall (2019): #27,384 of 560,194Top 5%
6
Patents 2019

Issued Patents 2019

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10472335 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet 2019-11-12
10358433 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more 2019-07-23
10336773 Neprilysin inhibitors Roland Gendron 2019-07-02
10315984 Neprilysin inhibitors Melissa Fleury 2019-06-11
10189823 Neprilysin inhibitors Melissa Fleury 2019-01-29
10172834 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2019-01-08